Chevron Corp

NYSE: CVX
$145.68
+$0.69 (+0.5%)
Closing Price on September 20, 2024

CVX Articles

The U.S. crude oil inventory posted it 10th consecutive weekly rise last week and prices, which had drifted lower Wednesday morning, first dipped lower then steadied.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.
The U.S. commercial crude oil inventory rose more than expected last week. Stockpiles of gasoline and diesel fuel dropped, and U.S. crude oil production remained at all-time highs.
Oil has traded down into bear market territory, and there are numerous reason it could rally next year. So what should concerned investors do now?
The U.S. crude oil stockpile soared by more than 10 million barrels last week according to the latest official report. Inventories have now risen for eight consecutive weeks.
The October 31 short interest data have been compared with the previous figures, and short interest moves in these selected big oil stocks were mixed.
Exxon Mobil, Caterpillar, Chevron, and Disney were the anchors holding the Dow lower Thursday.
These four large-cap growth stocks all pay reliable dividends, have backed up to much more reasonable entry points and offer investors good upside potential.
The U.S. commercial crude oil inventory rose by nearly 6 million barrels last week while gasoline inventories rose by nearly 2 million barrels. Falling prices will get no boost from this report.
CVS reported third-quarter results Tuesday morning that beat estimates on both the top and bottom lines. The company also said it expects to close its acquisition of Aetna by Thanksgiving.
November 5, 2018: Markets opened mixed Monday as the Nasdaq Composite failed to generate any positive sentiment until late in the day. But tech sector stocks underperformed all day and ended up being...
Last week's earnings brigade included oil giants Chevron and Exxon Mobil. Now Wall Street analyst is calling for Chevron to be a better value than its rival.
The top analyst upgrades, downgrades and initiations seen on Monday included Adamas Pharmaceuticals, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva Pharmaceutical and Under...
  This last week was a crazy end to the October selling craze being followed by a flood of stock buying this week prior to Friday’s major profit taking. Some of that buying is obviously being...
Chevron beat the third-quarter consensus profit estimate but was light on revenue. Higher prices and increased volume